It should be noted that high expression of these immune checkpoints may lead to suppressed antitumor immunity in patients with high CXCR4 expression, and these findings also prompted our study of the prognostic value of CXCR4 in NSCLC patients. Here, CXCR4 is linked to non-small cell lung carcinoma.